Evidence map›Paper›PMID 29594222›Full record

ArticleClinical and translational radiation oncology2017

The impact of the IGF-1 system of cancer cells on radiation response - An

Senthiladipan Venkatachalam, Esther Mettler, Christian Fottner, Matthias Miederer, Bernd Kaina, Matthias M Weber

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. IGF-1R depletion sensitizes colon cancer cell lines to radiotherapy.Cancer biomarkers : section A of Disease markers · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Senthiladipan VenkatachalamDepartment of Endocrinology and Metabolic Diseases, University Medical Center, Mainz, Germany.
Esther MettlerDepartment of Endocrinology and Metabolic Diseases, University Medical Center, Mainz, Germany.
Christian FottnerDepartment of Endocrinology and Metabolic Diseases, University Medical Center, Mainz, Germany.
Matthias MiedererDepartment of Nuclear Medicine, University Medical Center, Mainz, Germany.
Bernd KainaInstitute of Toxicology, University Medical Center, Mainz, Germany.
Matthias M WeberDepartment of Endocrinology and Metabolic Diseases, University Medical Center, Mainz, Germany.
Johannes Gutenberg University Mainz · DEUniversity Medical Center of the Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOverexpression of the insulin-like growth factor-1 receptor (IGF-1R) is associated with increased cell proliferation, differentiation, transformation, and tumorigenicity. Additionally, signaling involved in the resistance of cancer cells to radiotherapy originates from IGF-1R. The purpose of this study was to investigate the role of the IGF-1 system in the radiation response and further evaluate its effect on the expression of DNA repair pathway genes.

methodsTo inhibit the IGF-1 system, we stably transfected the Caco-2 cell line to express a kinase-deficient IGF-1R mutant. We then studied the effects of this mutation on cell growth, the response to radiation, and clonogenic survival, as well as using a cell viability assay to examine DNA damage and repair. Finally, we performed immunofluorescence for γ-H2AX to examine double-strand DNA breaks and evaluated the expression of 84 key genes involved in DNA repair with a real-time PCR array.

resultsMutant IGF-1R cells exhibited significantly blunted cell growth and viability, compared to wild-type cells, as well as reduced clonogenic survival after γ-irradiation. However, mutant IGF-1R cells did not show any significant delays in the repair of radiation-induced DNA double-strand breaks. Furthermore, expression of mutant IGF-1R significantly down-regulated the mRNA levels of BRCA2, a major protein involved in homologous recombination DNA repair.

conclusionThese results indicate that blocking the IGF-1R-mediated signaling cascade, through the expression of a kinase-deficient IGF-1R mutant, reduces cell growth and sensitizes cancer cells to ionizing radiation. Therefore, the IGF-1R system could be a potential target to enhance radio-sensitivity and the efficacy of cancer treatments.

Indexed as

BAX, BCL-2-associated XBCL-2, B-cell lymphoma 2BRCA2Caco-2-KR4, IGF-1R/KR clone number 4Colorectal carcinmomaDominant negative mutantHRR, homologous recombination repairIGF-1R, insulin-like growth factor 1 receptorIGF-1R/KR, kinase-deficient IGF-1RInsulin-like growth factor-1 receptorIRS-1, insulin receptor substrate 1MVP, major vault proteinNHEJ, non-homologous end joiningPTEN, phosphatase and tensin homologRAD 51RadiosensitivitySF, surviving fractions

Identifiers

PMID29594222
PMCPMC5862664
OpenAlexW2762684766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.